Discovery of a new boron-containing antifungal agent, 5-fluoro-1,3-dihydro-1-hydroxy-2,1- benzoxaborole (AN2690), for the potential treatment of onychomycosis.
Stephen J Baker, Yong-Kang Zhang, Tsutomu Akama, Agnes Lau, Huchen Zhou, Vincent Hernandez, Weimin Mao, M R K Alley, Virginia Sanders, Jacob J Plattner
Index: J. Med. Chem. 49(15) , 4447-50, (2006)
Full Text: HTML
Abstract
A structure-activity relationship investigation for a more efficacious therapy to treat onychomycosis, a fungal infection of the toe and fingernails, led to the discovery of a boron-containing small molecule, 5-fluoro-1,3-dihydro-1-hydroxy-2,1-benzoxaborole (AN2690), which is currently in clinical trials for onychomycosis topical treatment.
Related Compounds
Related Articles:
5-Fluoro-1,3-dihydro-2,1-benzoxaborol-1-ol.
2011-01-01
[Acta Crystallogr. Sect. E Struct. Rep. Online 67(Pt 2) , o414-5, (2011)]
2-Bromo-5-fluorobenzaldehyde. Tureski RE and Tanski JM.
[Acta Crystallogr. Sect. E Struct. Rep. Online 69(8) , o1246-o1246, (2013)]
Nuclear spin-spin coupling via nonbonded interactions. 4. Fluorine-fluorine and hydrogen-fluorine coupling in substituted benzo [c] phenanthrenes. Mallory FB, et al.
[J. Org. Chem. 50(4) , 457-461, (1985)]